CDKN2A and meningioma: Importantly, CDKN2Alow meningiomas actually appeared to have an intermediate level of CDKN2A mRNA expression, higher than the “null” level of expression seen in CDKN2A homodel cases but lower than the highest levels of expression observed in the CDKN2Ahigh cases (Supplementary Fig. 3a).